Heart-Derived Stem Cells in Miniature Swine with Coronary Microembolization: Novel Ischemic Cardiomyopathy Model to Assess the Efficacy of Cell-Based Therapy

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Suzuki, Gen ^a   Young, Rebeccah F ^a   Leiker, Merced M ^a   Suzuki, Takayuki ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; MICROSPHERE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERIAL WALL THICKENING; ARTICLE; CARDIAC MUSCLE CELL; CARDIOSPHERE DERIVED CELL; CELL COUNT; CELL DENSITY; CELL REGENERATION; CELL SIZE; CELL THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE DURATION; HEART FUNCTION; HEART INFARCTION SIZE; HYPERTROPHY; ISCHEMIC CARDIOMYOPATHY; MICROEMBOLISM; MINIPIG; MITOSIS; MYOCYTE PROLIFERATION; NONHUMAN; STEM CELL; STEM CELL TRANSPLANTATION;

EID: 84990818590     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/6940195     Document Type: Article

References (44)

1. K. H. Schuleri, G. S. Feigenbaum, M. Centola et al., "Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy, " European Heart Journal, vol. 30, no. 22, pp. 2722-2732, 2009.
2. K. E. Hatzistergos, H. Quevedo, B. N. Oskouei et al., "Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation, " Circulation Research, vol. 107, no. 7, pp. 913-922, 2010.
3. P. V. Johnston, T. Sasano, K. Mills et al., "Engraftment, differentiation, and functional benefits of autologous cardiospherederived cells in porcine ischemic cardiomyopathy, " Circulation, vol. 120, no. 12, pp. 1075-1083, 2009.
4. V. Schächinger, B. Assmus, M. B. Britten et al., "Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCAREAMI trial, " Journal of the American College of Cardiology, vol. 44, no. 8, pp. 1690-1699, 2004.
5. J. M. Hare, J. E. Fishman, G. Gerstenblith et al., "Comparison of allogeneic vs autologous bonemarrow-derivedmesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial, " The Journal of the AmericanMedical Association, vol. 308, no. 22, pp. 2369-2379, 2012.
6. A. R. Williams, B. Trachtenberg, D. L. Velazquez et al., "Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling, " Circulation Research, vol. 108, no. 7, pp. 792-796, 2011.
7. A. R. Chugh, G. M. Beache, J. H. Loughran et al., "Administration of cardiac stem cells in patients with ischemic cardiomyopathy: The SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance, " Circulation, vol. 126, no. 11, pp. S54-S64, 2012.
8. R. R. Makkar, R. R. Smith, K. Cheng et al., "Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial, " The Lancet, vol. 379, no. 9819, pp. 895-904, 2012.
9. R. Bolli, A. R. Chugh, D. D'Amario et al., "Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial, " The Lancet, vol. 378, no. 9806, pp. 1847-1857, 2011.
10. I. Chimenti, R. R. Smith, T.-S. Li et al., "Relative roles of direct regeneration versus paracrine effects of human cardiospherederived cells transplanted into infarcted mice, " Circulation Research, vol. 106, no. 5, pp. 971-980, 2010.
11. T.-S. Li, K. Cheng, K. Malliaras et al., "Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells, " Journal of the American College of Cardiology, vol. 59, no. 10, pp. 942-953, 2012.
12. K. Malliaras, R. R. Makkar, R. R. Smith et al., "Intracoronary cardiosphere-derived cells aftermyocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (cardiosphere-derived autologous stem cells to reverse ventricular dysfunction), " Journal of the American College of Cardiology, vol. 63, no. 2, pp. 110-122, 2014.
13. G. Heusch, R. Schulz, M. Haude, and R. Erbel, "Coronary microembolization, " Journal of Molecular and Cellular Cardiology, vol. 37, no. 1, pp. 23-31, 2004.
14. A. Skyschally, K. Leineweber, P. Gres, M. Haude, R. Erbel, and G. Heusch, "Coronary microembolization, " Basic Research in Cardiology, vol. 101, no. 5, pp. 373-382, 2006.
15. W. M. Yarbrough and F. G. Spinale, "Large animal models of congestive heart failure: A critical step in translating basic observations into clinical applications, " Journal ofNuclear Cardiology, vol. 10, no. 1, pp. 77-86, 2003.
16. M. Thielmann, H. Dörge, C. Martin et al., "Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-, and sphingosine, " Circulation Research, vol. 90, no. 7, pp. 807-813, 2002.
17. M. Canton, A. Skyschally, R. Menabò et al., "Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization, " European Heart Journal, vol. 27, no. 7, pp. 875-881, 2006.
18. G. Heusch, P. Kleinbongard, D. Böse et al., "Coronarymicroembolization: from bedside to bench and back to bedside, " Circulation, vol. 120, no. 18, pp. 1822-1836, 2009.
19. H. N. Sabbah, M. P. Chandler, T. Mishima et al., "Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure, " Journal of Cardiac Failure, vol. 8, no. 6, pp. 416-422, 2002.
20. M. Carlsson, A. J. Martin, P. C. Ursell, D. Saloner, andM. Saeed, "Magnetic resonance imaging quantification of left ventricular dysfunction following coronary microembolization, " Magnetic Resonance in Medicine, vol. 61, no. 3, pp. 595-602, 2009.
21. S. R. Houser, K. B. Margulies, A. M. Murphy et al., "Animal models of heart failure: A scientific statement from the American Heart Association, " Circulation Research, vol. 111, no. 1, pp. 131-150, 2012.
22. G. Suzuki, B. R. Weil, M. M. Leiker et al., "Global intracoronary infusion of allogeneic cardiosphere-derived cells improves ventricular function and stimulates endogenous myocyte regeneration throughout the heart in swine with hibernating myocardium, " PLoS ONE, vol. 9, no. 11, Article ID e113009, 2014.
23. G. Heusch and R. Schulz, "Perfusion-contraction match and mismatch, " Basic Research in Cardiology, vol. 96, no. 1, pp. 1-10, 2001.
24. H. N. Sabbah, V. G. Sharov, R. C. Gupta, A. Todor, V. Singh, and S. Goldstein, "Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure, " Journal of the American College of Cardiology, vol. 36, no. 5, pp. 1698-1705, 2000.
25. A. Schmermund, L. O. Lerman, J. A. Rumberger et al., "Effects of acute and chronic angiotensin receptor blockade onmyocardial vascular blood volume and perfusion in a pigmodel of coronary microembolization, " American Journal of Hypertension, vol. 13, no. 7, pp. 827-837, 2000.
26. A. Skyschally, R. Schulz, R. Erbel, and G. Heusch, "Reduced coronary and inotropic reserves with coronary microembolization, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 282, no. 2, pp. H611-H614, 2002.
27. R. R. Smith, L. Barile, H. C. Cho et al., "Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens, " Circulation, vol. 115, no. 7, pp. 896-908, 2007.
28. G. Suzuki, V. Iyer, T.-C. Lee, and J. M. Canty Jr., "Autologous mesenchymal stem cells mobilize cKit+ and CD133+ bone marrow progenitor cells and improve regional function in hibernating myocardium, " Circulation Research, vol. 109, no. 9, pp. 1044-1054, 2011.
29. B. J. Malm, G. Suzuki, J. M. Canty Jr., and J. A. Fallavollita, "Variability of contractile reserve in hibernating myocardium: dependence on the method of inotropic stimulation, " Cardiovascular Research, vol. 56, no. 3, pp. 422-432, 2002.
30. J. A. Fallavollita and J. M. Canty Jr., "Ischemic cardiomyopathy in pigs with two-vessel occlusion and viable, chronically dysfunctional myocardium, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 282, no. 4, pp. H1370-H1379, 2002.
31. J. A. Fallavollita, B. J. Perry, and J. M. Canty Jr., " 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium: evidence for transmural variations in chronic hibernatingmyocardium, " Circulation, vol. 95, no. 7, pp. 1900-1909, 1997.
32. J. A. Fallavollita, M. Logue, and J. M. Canty Jr., "Stability of hibernating myocardium in pigs with a chronic left anterior descending coronary artery stenosis: Absence of progressive fibrosis in the setting of stable reductions in flow, function and coronary flow reserve, " Journal of the American College of Cardiology, vol. 37, no. 7, pp. 1989-1995, 2001.
33. G. Suzuki, T.-C. Lee, J. A. Fallavollita, and J. M. Canty Jr., "Adenoviral gene transfer of FGF-5 to hibernatingmyocardium improves function and stimulatesmyocytes to hypertrophy and reenter the cell cycle, " Circulation Research, vol. 96, no. 7, pp. 767-775, 2005.
34. L. Hajin, J. A. Fallavollita, R. Hard, C. W. Kerr, and J. M. Canty Jr., "Profound apoptosis-mediated regional myocyte loss and compensatory hypertrophy in pigs with hibernating myocardium, " Circulation, vol. 100, no. 23, pp. 2380-2386, 1999.
35. P. Lynch, T.-C. Lee, J. A. Fallavollita, J. M. Canty Jr., and G. Suzuki, "Intracoronary administration of AdvFGF-5 (fibroblast growth factor-5) ameliorates left ventricular dysfunction and prevents myocyte loss in swine with developing collaterals and ischemic cardiomyopathy, " Circulation, vol. 116, no. 11, pp. I71-I76, 2007.
36. P. C. H. Hsieh, V. F. M. Segers, M. E. Davis et al., "Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury, " Nature Medicine, vol. 13, no. 8, pp. 970-974, 2007.
37. G. Suzuki, V. Iyer, T. Cimato, and J. M. Canty Jr., "Pravastatin improves function in hibernating myocardium by mobilizing CD133+ and cKit+ bonemarrow progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle, " Circulation Research, vol. 104, no. 2, pp. 255-264, 2009.
38. F. S. Loffredo, M. L. Steinhauser, J. Gannon, and R. T. Lee, "Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair, " Cell Stem Cell, vol. 8, no. 4, pp. 389-398, 2011.
39. S. E. Senyo, M. L. Steinhauser, C. L. Pizzimenti et al., "Mammalian heart renewal by pre-existing cardiomyocytes, " Nature, vol. 493, no. 7432, pp. 433-436, 2013.
40. E. Tseliou, S. Pollan, K. Malliaras et al., "Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains, " Journal of the American College of Cardiology, vol. 61, no. 10, pp. 1108-1119, 2013.
41. G. Suzuki, "Translational research of adult stem cell therapy, " World Journal of Cardiology, vol. 7, no. 11, pp. 707-718, 2015.
42. C. Piot, P. Croisille, P. Staat et al., "Effect of cyclosporine on reperfusion injury in acute myocardial infarction, " The New England Journal of Medicine, vol. 359, no. 5, pp. 473-481, 2008.
43. S. J. JansenofLorkeers, E. Hart, X. L. Tang et al., "Cyclosporin in cell therapy for cardiac regeneration, " Journal of Cardiovascular Translational Research, vol. 7, no. 5, pp. 475-482, 2014.
44. G. Heusch, "CIRCUS: A kiss of death for cardioprotection" Cardiovascular Research, vol. 108, no. 2, pp. 215-216, 2015.